Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Collegium Pharmaceutical ( (COLL) ) has issued an announcement.
On February 3, 2025, Collegium Pharmaceutical, Inc. announced the expansion of its board of directors from eight to nine members, appointing Nancy Lurker as a new director effective February 4, 2025. Lurker, who has extensive experience in the pharmaceutical industry, will serve until the 2025 Annual Meeting of Shareholders. Her appointment follows her role as Vice Chair at EyePoint Pharmaceuticals and a history of executive positions at several prominent pharmaceutical companies. The appointment aligns with Collegium’s strategic governance enhancements and marks a significant addition to its leadership, potentially strengthening its industry standing.
More about Collegium Pharmaceutical
YTD Price Performance: 8.03%
Average Trading Volume: 474,371
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.01B
Learn more about COLL stock on TipRanks’ Stock Analysis page.
